Life Sciences

While millions of Americans have learned to work from home, developing COVID-19 vaccines requires office and lab space.

Marlborough medical device company Boston Scientific has released newly obtained study data speaking to the effectiveness of its TheraSphere Y-90 Glass Microspheres cancer treatment.

Cytovia Therapeutics, a biopharmaceutical manufacturer of cancer-fighting cell therapies, has expanded its research and development operations with a new lab in Natick opened this month.

Marlborough medical device company Boston Scientific has received U.S. Food and Drug Administration approval for its TheraSphere Y-90 Glass Microspheres cancer treatment.

NyLa Laboratories, a Worcester startup based at Massachusetts Biomedical Initiatives, known more commonly as MBI, has received certification to open a lab for a COVID-19 diagnostic testing, according to a Tuesday announcement.

Holliston biotechnology firm Harvard Bioscience returned to pre-COVID-19 revenue levels in the fourth quarter, but the company’s financial performance was still down overall for the year when compared to 2019.

Marlborough medical device company Hologic has made yet another acquisition, this time picking up Belgium-based diagnostic company Diagenode for $159 million.

Marlborough medical device company Boston Scientific announced Wednesday that it has entered into an agreement to acquire the global surgical business of Lumenis LTD.

The Massachusetts biopharmaceutical industry raised far more investment than ever before in 2020, coinciding with the coronavirus pandemic that shifted an emphasis to potential lifesaving drugs, according to a report released Thursday.

Phio Pharmaceuticals Corp., a publicly-traded biotechnology firm, has closed its previously announced public offering of 2,246,784 shares of common stock, at a purchase price of $3.42 per share.